|
1. |
The Effect of Topical Steroid on the Actions of Vasoconstrictor and Vasodilator Peptides in Human Skin |
|
Skin Pharmacology and Physiology,
Volume 9,
Issue 5,
1996,
Page 289-297
Portia Goldsmith,
Christopher Bunker,
Tabi Leslie,
John Foreman,
Pauline M. Dowd,
Preview
|
PDF (2920KB)
|
|
摘要:
The effect of topical application of clobetasol propionate ointment (0.05% w/v) on the vascular changes induced by intradermal injections of histamine, calcitonin gene-related peptide, substance P, endothelin-1 and compound 48/80 was studied. Clobetasol propionate ointment was applied topically under occlusion to the forearm skin of healthy volunteers and vehicle base was applied to the contralateral forearm. The intradermal injections were made 4 h or, in a separate study, 72 h after topical steroid application. Responses were measured by planimetry and laser Doppler flowmetry. Four hours application of steroid did not significantly alter the responses to any of the vasoactive substances. After 72 hours application, clobetasol propionate significantly increased the size of the endothelin-1-induced area of vasoconstriction (p < 0.02) and significantly reduced the size of the flares induced by endothelin-1 (p < 0.02), substance P (p < 0.009) and compound 48/80 (p < 0.05). We conclude that the most likely explanation of our data is an inhibition by the steroid of cutaneous mast cell function.
ISSN:1660-5527
DOI:10.1159/000211427
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
2. |
Evaluation of Topical Antipsoriatic Treatment by Chromametry, Visiometry and 20-MHz Ultrasound in the Psoriasis Plaque Test |
|
Skin Pharmacology and Physiology,
Volume 9,
Issue 5,
1996,
Page 298-306
E. Bangha,
P. Elsner,
Preview
|
PDF (3062KB)
|
|
摘要:
The antipsoriatic effects of two topical antipsoriatic agents, betamethasone valerate (Betnovate®) and calcipotriol (Dai-vonex®), and a pure nanocolloid gel were assessed in 10 patients with chronic plaque-type psoriasis in a modified psoriasis plaque test. Three noninvasive bioengineering methods were applied to measure antipsoriatic effects: chromametry for objective evaluation of erythema; visiometry, a method for profilometry, and 20-MHz skin ultrasound for the measurement of skin thickness as a parameter of inflammatory infiltration and psoriatic hyperproliferation of the epidermis. Regarding inflammation parameters such as skin thickness (infiltration) and erythema (dilatation of vessels and hyperperfusion), the steroid preparation Betnovate proved to be significantly most effective in our study. Daivonex showed significant decreases in the skin roughness parameters, underlining its antiproliferative effect. The nanocolloid carrier was significantly effective in thickness reduction, this effect being most probably due to occlusion. 20-MHz ultrasound, chromametry and visiometry proved to provide multiparameter assessment of treated and untreated psoriatic skin and can be recommended as objective and reproducible measurements for further studie
ISSN:1660-5527
DOI:10.1159/000211428
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
3. |
Topical R-85355, a Potent and Selective 5-Lipoxygenase Inhibitor, Fails To Improve Psoriasis |
|
Skin Pharmacology and Physiology,
Volume 9,
Issue 5,
1996,
Page 307-311
P.C.M. van de Kerkhof,
H. van Pelt,
G.P.H. Lucker,
P.M. Steijlen,
A. Heremans,
Preview
|
PDF (1523KB)
|
|
摘要:
Inhibitors of 5-lipoxygenase have been studied with respect to antipsoriatic efficacy. Of these compounds, R-68151 is of particular interest as it proved to inhibit 5-lipoxygenase without inhibiting 12-lipoxygenase, cyclooxygenase and thromboxane-A2 synthetase. R-68151 has been shown to have a mild-to-moderate therapeutic effect in psoriasis. In the present study a new 5-lipoxygenase, R-85355, was investigated with respect to its efficacy in psoriasis. R-85355 is 3 times more potent compared to R-68151 with respect to inhibition of in vitro A-23187-stimulated leukotriene-B4 production by polymorpho-nuclear leukocytes. In a left-right double-blind comparative study, the compound was studied at saturation with respect to its antipsoriatic efficacy in 11 patients with chronic stable plaque psoriasis. In addition, various markers for epidermal proliferation, keratinization and inflammation were assessed. In no single patient was a left-right difference observed in favour of R-85355 compared to placebo with respect to clinical severity scores or the cell-biological markers. The present study indicates that a selective and highly potent 5-lipoxygenase inhibitor was not effective in the topical treatment of chronic plaque psoriasis.
ISSN:1660-5527
DOI:10.1159/000211431
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
4. |
Regional Variation of Nonimmunologic Contact Urticaria |
|
Skin Pharmacology and Physiology,
Volume 9,
Issue 5,
1996,
Page 312-321
David L. Shriner,
Howard I. Maibach,
Preview
|
PDF (3320KB)
|
|
摘要:
Background and Design: Benzoic acid (BA) was used to induce nonimmunologic contact irritation in 10 younger (23-47 years old) and 5 older (72-90 years old) healthy volunteers. BA2.5% in petrolatum was applied to 8 locations on the face, neck and volar forearm. Changes in the skin blood flow were monitored using a laser Doppler flowmeter. Also measured at each location were baseline measurements of skin blood flow, transepidermal water loss, stratum corneum hydration, skin surface temperature and skin surface pH. Results: The neck area exhibited the greatest reaction in both age groups while the forearm exhibited the least. At each site tested, the younger group consistently demonstrated greater reactivity to BA. A significant correlation was noted between stratum corneum hydration and irritation. Conclusion: This information provides a basis to further study the frequent poorly understood intolerance of the face to topical formulation.
ISSN:1660-5527
DOI:10.1159/000211433
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
5. |
Plasma Retinoids after Topical Use of Retinaldehyde on Human Skin |
|
Skin Pharmacology and Physiology,
Volume 9,
Issue 5,
1996,
Page 322-326
J.O. Sass,
E. Masgrau,
P.A. Piletta,
H. Nau,
J.-H. Saurat,
Preview
|
PDF (1594KB)
|
|
摘要:
Background: Retinaldehyde (RAL), a natural metabolite of β-carotene and retinol (ROL), is tolerated by human skin after topical application. Purpose: To see if topical application of a large quantity of RAL on human skin is associated with a detectable alteration of constitutive levels of plasma retinoids resulting from metabolism of RAL in the skin. Methods: Plasma retinoids [ROL, all-trans-retinoic acid (all-trans-RA), RAL, retinyl palmitate/oleate, 13-cis-RA and 4-oxo-13-cis-RA] were analyzed by high-pressure liquid chromatography. Determinations were done in 10 healthy male volunteers kept on a vitam-A-poor diet before, during and after daily topical application of 7 mg of RAL to 40% of the body surface for 14 days. Results: The introduction of a restricted vitamin A diet before RAL application resulted in a decrease in the plasma levels of ROL, all-trans-RA and retinyl palmitate/oleate. Topical application of RAL did not induce an alteration of the plasma levels of retinoid metabolites. No RAL was detectable in any of the plasma samples. Conclusion: The skin metabolism of topically applied RAL does not result in detectable alterations of constitutive levels of plasma retinoids in humans
ISSN:1660-5527
DOI:10.1159/000211436
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
6. |
No Effect of Albumin on the Dermal Absorption Rate of Hydrocortisone 21-Butyrate, Permethrin or Diflunisal in the Isolated, Single-Pass Perfused Rabbit Ear |
|
Skin Pharmacology and Physiology,
Volume 9,
Issue 5,
1996,
Page 327-333
G.E. Bast,
H.G. Kampffmeyer,
Preview
|
PDF (2507KB)
|
|
摘要:
Rabbit ears were single-pass perfused with a buffer solution containing either 6% hetastarch or 5% bovine serum albumin. Hydrocortisone 21-butyrate (5 mM), diflunisal (17 mM) or permethrin (33 mM) was added to isopropyl myristate with 5% polyethylene, and applied to about 40% of the epithelial surface area of the ear. Hydrocortisone 21-butyrate or permethrin were not found in the effluent with hetastarch or albumin. Following cutaneous ester hydrolysis, the appearance rate of hydrocortisone was about 4 pmol/min per cm2 2,000 or when the xenobiotic is ionized at physiological pH. In general, for all substances investigated with our perfusion model thus far, the appearance rates decreased with rising distribution coefficient (n-octanol/buffer pH 7.4). High lipophilicity hinders the release from isopropyl myristate and the penetration through the skin.
ISSN:1660-5527
DOI:10.1159/000211438
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
7. |
A Model to Assess the Effectiveness of Topical Antipruritics |
|
Skin Pharmacology and Physiology,
Volume 9,
Issue 5,
1996,
Page 334-342
Ronald Drozdenko,
Stephen C. Pennisi,
Wilfred Minkin,
Howard Spivak,
Sidney Weinstein,
Curt Weinstein,
Preview
|
PDF (3147KB)
|
|
摘要:
A model has been developed to determine the effectiveness of topical antipruritics. It utilizes controlled, experimentally induced itch and has demonstrated the effectiveness of the direct action on cutaneous receptor sites of a topical anesthetic, benzocaine, in a topical antipruritic formulation, and has been used to differentiate between two effective topical antipruritics. Three studies are presented: The first study examined the reliability of the experimentally induced itch. Several indices of reliability were computed from the data of this first study. Cronbach’s alpha was 0.92. Winer’s theta also was 0.92. Simple test-retest reliability, computed at intervals of 29 min, 1 day, and 6-7 days, resulted in Pearson correlations of 0.84, 0.73, and 0.60, respectively. In the second study, the model differentiated statistically between the itch relief resulting from the topical application of a formulation with 6% benzocaine and the same formulation without benzocaine. The third study examined 2 known topical antipruritics: one containing 6% benzocaine and the other 1 % hydrocortisone. Both topical antipruritics were found to relieve itch; however, the benzocaine antipruritic produced statistically significantly greater itch relief in more subjects than the hydrocortisone antipruritic at both 1 and 30 min after application. These results demonstrate that OTC antipruritics can be differentiated for effectiven
ISSN:1660-5527
DOI:10.1159/000211441
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
|